142 related articles for article (PubMed ID: 26455276)
1. Fast dendritic cells matured with Poly (I:C) may acquire tolerogenic properties.
Pavlović B; Tomić S; Đokić J; Vasilijić S; Vučević D; Lukić J; Gruden-Movsesijan A; Ilić N; Marković M; Čolić M
Cytotherapy; 2015 Dec; 17(12):1763-76. PubMed ID: 26455276
[TBL] [Abstract][Full Text] [Related]
2.
Ilic N; Gruden-Movsesijan A; Cvetkovic J; Tomic S; Vucevic DB; Aranzamendi C; Colic M; Pinelli E; Sofronic-Milosavljevic L
Front Immunol; 2018; 9():11. PubMed ID: 29416536
[No Abstract] [Full Text] [Related]
3. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
5. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
6. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
7. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
8. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
9. Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics.
Esmaeili SA; Mahmoudi M; Rezaieyazdi Z; Sahebari M; Tabasi N; Sahebkar A; Rastin M
J Cell Biochem; 2018 Sep; 119(9):7865-7872. PubMed ID: 29943843
[TBL] [Abstract][Full Text] [Related]
10. Dendritic Cells Differentiated from Human Umbilical Cord Blood-Derived Monocytes Exhibit Tolerogenic Characteristics.
Kim SK; Yun CH; Han SH
Stem Cells Dev; 2015 Dec; 24(23):2796-807. PubMed ID: 26203805
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α promotes survival and phenotypic maturation of poly(I:C)-treated dendritic cells but impairs their Th1 and Th17 polarizing capability.
Thorne A; Tomić S; Pavlović B; Mihajlović D; Džopalić T; Čolić M
Cytotherapy; 2015 May; 17(5):633-46. PubMed ID: 25559144
[TBL] [Abstract][Full Text] [Related]
12. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
[TBL] [Abstract][Full Text] [Related]
13. The influence of CD40 ligation and interferon-gamma on functional properties of human monocyte-derived dendritic cells activated with polyinosinic-polycytidylic acid.
Dragicević A; Dzopalić T; Vasilijić S; Vucević D; Bozić B; Majstorović I; Balint B; Colić M
Vojnosanit Pregl; 2011 Apr; 68(4):301-8. PubMed ID: 21627015
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells generated in the presence of interferon-α and modulated with dexamethasone as a novel tolerogenic vaccine platform.
Leplina O; Kurochkina Y; Tikhonova M; Shevela E; Ostanin A; Chernykh E
Inflammopharmacology; 2020 Feb; 28(1):311-319. PubMed ID: 31552546
[TBL] [Abstract][Full Text] [Related]
15. Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco/endoplasmic reticulum Ca(2+) transport ATPase 2 regulation.
Choi NR; Lee HJ; Jung SH; Hong CY; Vo MC; Hoang MD; Kim HJ; Lee JJ
Cytotherapy; 2015 Oct; 17(10):1421-33. PubMed ID: 26212610
[TBL] [Abstract][Full Text] [Related]
16. TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties.
Song SS; Yuan PF; Chen JY; Fu JJ; Wu HX; Lu JT; Wei W
Immunol Invest; 2014; 43(4):360-9. PubMed ID: 24484319
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.
Zhang X; Kedl RM; Xiang J
Biochem Biophys Res Commun; 2009 Feb; 379(4):954-8. PubMed ID: 19135981
[TBL] [Abstract][Full Text] [Related]
18. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features.
Rutella S; Bonanno G; Procoli A; Mariotti A; de Ritis DG; Curti A; Danese S; Pessina G; Pandolfi S; Natoni F; Di Febo A; Scambia G; Manfredini R; Salati S; Ferrari S; Pierelli L; Leone G; Lemoli RM
Blood; 2006 Jul; 108(1):218-27. PubMed ID: 16527888
[TBL] [Abstract][Full Text] [Related]
20. Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.
Futalan D; Huang CT; Schmidt-Wolf IG; Larsson M; Messmer D
Mol Med; 2011; 17(9-10):910-6. PubMed ID: 21647537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
